subject area of
- A phase II study of ZD6474 (Zactima™), a selective inhibitor of VEGFR and EGFR tyrosine kinase in patients with relapsed multiple myeloma—NCIC CTG IND.145 Journal Articles
- A randomized trial of maintenance versus no maintenance melphalan and prednisone in responding multiple myeloma patients Journal Articles
- Antibodies to IGA in Pregnancy and in Recipient of Rho(D) Immune Globulin (Human) Journal Articles
- Late cutaneous allergic responses in isolated IgE-dependent reactions Journal Articles